Immunomodulatory Properties of Ketamine in Sepsis

NCT01089361 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Ketamine
DRUG: Normal Saline placebo

Sponsor

Beth Israel Deaconess Medical Center